A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-alpha, interferon-gamma and interleukin 1. Veröffentlicht vonadmin 27. Juli 1990 Geissler D, Gaggl S, MГ¶st J, Greil R, Herold M, Dietrich M. http://www.ncbi.nlm.nih.gov/pubmed/1980110